Financials
- Market Capitalization 1.83 B
- Employee 367
- Founded 2016
- CEO Marianne De Backer
- Website www.vir.bio
- Headquarter Delaware, United States
- FIGI BBG00H2QQ8T5
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-5.48
売上高対価格比率
5.42
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2028 | XNCR Xencor, Inc. - Common Stock | 26.70 USD | +2.46% | -6.81% | +33.77% | +228.01% | 1.99 B USD | ||
| 2051 | IMCR Immunocore Holdings plc - American Depositary Shares | 35.99 USD | -1.72% | -2.15% | +6.48% | +7.50% | 1.85 B USD | ||
| 2067 | INBX Inhibrx Biosciences, Inc. - Common Stock | 122.74 USD | -0.54% | +22.74% | +49.94% | +52.32% | 1.81 B USD | ||
| 2070 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.58 USD | -3.29% | -7.77% | -5.26% | +92.41% | 1.82 B USD |